Extracellular vesicles as a source for non‐invasive biomarkers in bladder cancer progression

[1]  Krisztina V. Vukman,et al.  Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection , 2016, Scientific Reports.

[2]  Carla Oliveira,et al.  Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. , 2016, ACS nano.

[3]  M. Yáñez-Mó,et al.  Extracellular Vesicles from BOEC in In Vitro Embryo Development and Quality , 2016, PloS one.

[4]  M. Yáñez-Mó,et al.  Comparative analysis of EV isolation procedures for miRNAs detection in serum samples , 2016, Journal of extracellular vesicles.

[5]  L. Schurgers,et al.  Apolipoprotein E Regulates Amyloid Formation within Endosomes of Pigment Cells. , 2015, Cell reports.

[6]  C. Qin,et al.  Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer , 2015, Scientific Reports.

[7]  A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer , 2015, Journal of experimental & clinical cancer research : CR.

[8]  Luis Carrasco,et al.  Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis , 2015, International journal of biological sciences.

[9]  T. He,et al.  The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2 , 2015, Clinical Cancer Research.

[10]  Lei Yu,et al.  Role of microRNA-30c Targeting ADAM19 in Colorectal Cancer , 2015, PloS one.

[11]  F. Borràs,et al.  Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases , 2015, Front. Immunol..

[12]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[13]  B. Liu,et al.  Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer. , 2014, Molecular medicine reports.

[14]  Kun-Chieh Chen,et al.  microRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18 , 2014, BMC Cancer.

[15]  Mustafa Özen,et al.  Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools , 2014, Molecular Biology Reports.

[16]  Sweta Rani,et al.  miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression , 2014, The Prostate.

[17]  G. Stein,et al.  hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3 , 2014, Cancer Cell International.

[18]  E. Messing,et al.  Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. , 2014, The Journal of urology.

[19]  Songbing He,et al.  MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway. , 2014, International journal of molecular medicine.

[20]  Michael R Green,et al.  miR-146a promotes the initiation and progression of melanoma by activating Notch signaling , 2014, eLife.

[21]  Wang Jing,et al.  Plasma microRNA profiles for bladder cancer detection. , 2013, Urologic oncology.

[22]  Lixue Chen,et al.  Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. , 2013, Molecular medicine reports.

[23]  R. Felder,et al.  Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure. , 2013, Clinical biochemistry.

[24]  Yu-Sun Chang,et al.  Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics. , 2013, Journal of proteomics.

[25]  P. Brambilla,et al.  Differential protein profiling of renal cell carcinoma urinary exosomes. , 2013, Molecular bioSystems.

[26]  L. Kiemeney,et al.  Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.

[27]  A. Geldof,et al.  Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients , 2013, Journal of extracellular vesicles.

[28]  G. Kristiansen,et al.  Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? , 2014, World Journal of Urology.

[29]  Chunxiang Zhang,et al.  A translational study of urine miRNAs in acute myocardial infarction. , 2012, Journal of molecular and cellular cardiology.

[30]  Jun Yang,et al.  A panel of five circulating microRNAs as potential biomarkers for prostate cancer , 2012, The Prostate.

[31]  V. Marshall,et al.  Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease , 2012, International journal of cancer.

[32]  D. Globe,et al.  Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA , 2012, Advances in urology.

[33]  F. Hamdy,et al.  Changes in circulating microRNA levels associated with prostate cancer , 2012, British Journal of Cancer.

[34]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[35]  S. Wickline,et al.  Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. , 2011, Cancer research.

[36]  J. Ellinger,et al.  Circulating microRNAs (miRNA) in serum of patients with prostate cancer. , 2011, Urology.

[37]  Antonio Alcaraz,et al.  MicroRNA in prostate, bladder, and kidney cancer: a systematic review. , 2011, European urology.

[38]  Fátima Sánchez-Cabo,et al.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells , 2011, Nature communications.

[39]  D. Lyden,et al.  The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.

[40]  Holger Sültmann,et al.  Circulating miRNAs are correlated with tumor progression in prostate cancer , 2011, International journal of cancer.

[41]  J. Redondo,et al.  A Robust Method for Quantitative High-throughput Analysis of Proteomes by 18O Labeling* , 2011, Molecular & Cellular Proteomics.

[42]  Takahiro Ochiya,et al.  Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis , 2010, Cancer science.

[43]  L. O’Driscoll,et al.  Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer , 2010, Breast Cancer Research and Treatment.

[44]  C. Stephan,et al.  Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors , 2010, Nature Reviews Urology.

[45]  Zhao-dian Chen,et al.  Up-regulation of microRNA in bladder tumor tissue is not common , 2010, International Urology and Nephrology.

[46]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[47]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[48]  Kedar S Vaidya,et al.  Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.

[49]  Joanne L Welton,et al.  Can urinary exosomes act as treatment response markers in prostate cancer? , 2009, Journal of Translational Medicine.

[50]  Y. Lotan,et al.  Urothelial bladder cancer: biomarkers for detection and screening , 2008, BJU international.

[51]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[52]  Donald C. Chang,et al.  Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.

[53]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[54]  Trairak Pisitkun,et al.  Discovery of Urinary Biomarkers* , 2006, Molecular & Cellular Proteomics.

[55]  K. Tsui,et al.  Searching cell‐secreted proteomes for potential urinary bladder tumor markers , 2006, Proteomics.

[56]  J. Witjes.  Management of BCG failures in superficial bladder cancer: a review. , 2006, European urology.

[57]  L. Holzman,et al.  Clinical impact of research on the podocyte slit diaphragm , 2006, Nature Clinical Practice Nephrology.

[58]  M. Soloway,et al.  The diagnosis and staging of bladder cancer: from RBCs to TURs. , 2006, Urology.

[59]  T. Değirmenci,et al.  Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin , 2005, Urologia Internationalis.

[60]  T. Deix,et al.  The role of urinary cytology for detection of bladder cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[61]  J. Montie.  Prognosis of Muscle-Invasive Bladder Cancer: Difference Between Primary and Progressive Tumours and Implications for Therapy , 2005 .

[62]  F. Burkhard,et al.  Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? , 2004, The Journal of urology.

[63]  W. Turner.  T1G3 bladder tumours: the case for conservative treatment. , 2004, European urology.

[64]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[65]  N. Smith,et al.  Renal tumors in young adults. , 2004, The Journal of urology.

[66]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[67]  U. Studer,et al.  Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin. , 2000, The Journal of urology.

[68]  E. Fearon,et al.  Cancer progression , 1999, Current Biology.

[69]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[70]  W. Catalona,et al.  Urothelial Tumors of the Urinary Tract , 1992 .

[71]  P. Hartge,et al.  Urinary tract infection and risk of bladder cancer. , 1984, American journal of epidemiology.